No Data
No Data
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast
Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers Across 15 U.S. States
Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21
H.C. Wainwright Maintains Co-diagnostics(CODX.US) With Hold Rating, Maintains Target Price $2
Express News | HC Wainwright & Co. Reiterates Neutral on Co-Diagnostics, Maintains $2 Price Target
Express News | Co-Diagnostics Submits FDA Application For 510(k) Clearance Of Co-Dx PCR Pro Instrument And OTC COVID-19 Test; POC Clearance And Additional Tests To Follow
No Data